Investigation of the Effects of Interlaminar Epidural Steroid Injection on Upper Extremity Proprioception in Patients With Chronic Cervical Radiculopathy

NCT ID: NCT07307846

Last Updated: 2025-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-25

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cervical radiculopathy is a common condition caused by irritation or compression of cervical nerve roots, often leading to unilateral neuropathic pain and functional impairment. Proprioceptive deficits in the upper extremity have been demonstrated in various cervical spine disorders; however, the effect of interlaminar epidural steroid injection (ILESI) on upper extremity proprioception in patients with chronic cervical radiculopathy has not been previously examined.

This prospective interventional study aims to evaluate changes in upper extremity proprioception following unilateral ILESI in patients with cervical disc herniation-related chronic radiculopathy. A secondary aim is to investigate the relationship between proprioceptive changes and clinical outcomes such as pain, neuropathic pain, disability, grip strength, and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cervical radiculopathy is characterized by neuropathic pain radiating along a dermatomal pattern due to irritation or compression of cervical nerve roots, most commonly from cervical disc herniation or foraminal narrowing. In addition to sensory symptoms, proprioceptive deficits may arise from altered cervical afferent input, affecting upper extremity joint position sense and sensorimotor control. Although proprioceptive impairment has been previously demonstrated in chronic neck pain and cervical spondylosis, the proprioceptive profile of patients with cervical radiculopathy has not been adequately investigated.

Interlaminar epidural steroid injection (ILESI) is a commonly used minimally invasive treatment for cervical disc herniation-associated radicular pain and has been shown to reduce pain and improve function and disability. However, its potential effects on upper extremity proprioception, an important sensory component contributing to coordinated movement and rehabilitation outcomes, remain unknown.

This prospective interventional study will evaluate proprioceptive changes using the PRO-Reach upper extremity joint position sense test, a validated multi-planar assessment method that measures joint position error across multiple directions without requiring computerized or robotic devices. Clinical outcome measures will include neuropathic pain scores, pain intensity, disability indices, hand-grip strength, and health-related quality of life. All assessments will be performed at three time points: before treatment (T0), 3 weeks after injection (T1), and 3 months after injection (T2).

Participants will undergo standardized unilateral ILESI at the C7-T1 interlaminar level under fluoroscopic guidance using a combination of corticosteroid, local anesthetic, and saline. Data collection will be performed by blinded assessors to minimize measurement bias.

The study aims to characterize whether ILESI provides measurable improvements in upper extremity proprioception and to determine the extent to which changes in proprioceptive accuracy correspond to changes in pain, neuropathic symptoms, upper extremity function, and quality of life. These findings may help guide rehabilitation planning and provide insight into the sensorimotor consequences of cervical radiculopathy and its interventional treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Radiculopathy Cervical Radicular Pain Proprioception

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

cervical radiculopathy cervical radicular pain interlaminar epidural steroid injection proprioception proprioceptive impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cervical Radiculopathy- Interlaminar Epidural Steroid Injection (ILESI) Group

Participants diagnosed with chronic unilateral cervical radiculopathy due to cervical disc herniation will undergo a standardized interlaminar epidural steroid injection. All evaluations (proprioception, pain, neuropathic pain, disability, grip strength, and quality of life) will be performed at baseline (T0), 3 weeks post-procedure (T1), and 3 months post-procedure (T2).

Group Type ACTIVE_COMPARATOR

Interlaminar Epidural Steroid Injection (ILESI)

Intervention Type PROCEDURE

The injection will be administered under sterile conditions with fluoroscopic guidance at the C7-T1 interlaminar level. An 18-gauge epidural needle will be advanced into the epidural space, followed by injection of a mixture containing: 80 mg triamcinolone acetonide, 1 mL of 2% lidocaine, and 2 mL of 0.9% saline.

Participants will remain under observation for approximately 2 hours after the procedure and will then be discharged. The procedure will be performed by an experienced pain medicine specialist with over 15 years of fluoroscopic interventional practice.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interlaminar Epidural Steroid Injection (ILESI)

The injection will be administered under sterile conditions with fluoroscopic guidance at the C7-T1 interlaminar level. An 18-gauge epidural needle will be advanced into the epidural space, followed by injection of a mixture containing: 80 mg triamcinolone acetonide, 1 mL of 2% lidocaine, and 2 mL of 0.9% saline.

Participants will remain under observation for approximately 2 hours after the procedure and will then be discharged. The procedure will be performed by an experienced pain medicine specialist with over 15 years of fluoroscopic interventional practice.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participants must meet all of the following:

* Female or male, 18-65 years of age
* Presence of unilateral cervical radicular pain lasting at least 3 months
* MRI of the cervical spine within the last 12 months demonstrating at least one cervical disc herniation consistent with the patient's symptoms
* Diagnosed with chronic cervical radiculopathy based on history, physical examination, and clinical evaluation
* Ability to read and write (literacy)
* Willingness to participate and ability to provide written informed consent

Exclusion Criteria

Participants will be excluded for any of the following:

* Cervical physical therapy or cervical spinal injection performed within the past 6 months
* Symptoms or diagnosis of upper extremity entrapment neuropathy
* Documented vitamin B12 deficiency or vitamin D deficiency on laboratory results within the past year
* History of cervical spine surgery or significant cervical trauma
* Bilateral cervical radicular pain
* Cervical spinal stenosis
* History of upper extremity surgery or significant upper extremity trauma
* Cognitive impairment, major psychiatric disorder, intellectual disability, or history of significant neurological disease
* Diagnosis of polyneuropathy
* Diagnosis of Diabetes Mellitus
* Diagnosis of fibromyalgia
* Current use of medications that may impair proprioception or have sedative effects (e.g., gabapentinoids, antidepressants, muscle relaxants)
* Active local or systemic infection
* Coagulopathy or bleeding diathesis
* Known allergy to any components of the planned injection (triamcinolone, lidocaine, saline, contrast medium)
* Pregnancy
* Inability or unwillingness to provide informed consent
* Illiteracy (unable to read or write)

Withdrawal Criteria

* Voluntary withdrawal of consent at any time
* Inability or unwillingness to continue study participation for any reason
* New medical condition or event after enrollment that renders continuation unsafe according to the investigator's judgment
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Marmara University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Savaş Şencan, Assoc. Prof., Pain Medicine

Role: STUDY_DIRECTOR

Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Marmara University Pendik Training and Research Hospital

Pendik, Istanbul, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gökçenur Yalçın, M.D., PMR Specialist

Role: CONTACT

Phone: +90 216 625 45 45

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gökçenur Yalçın, M.D., PMR Specialist

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Marmara-FTR-GNY-03

Identifier Type: -

Identifier Source: org_study_id